Literature DB >> 96117

Biochemical and immunological characterization of human opsonic alpha2SB glycoprotein: its identity with cold-insoluble globulin.

F A Blumenstock, T M Saba, P Weber, R Laffin.   

Abstract

The relationship between human cold-insoluble globulin (CIg, plasma fibronectin) and the human serum opsonic alpha2SB glycoprotein was investigated using immunochemical and biochemical techniques. The two proteins appeared to have identical molecular weights by sodium dodecyl sulfate-polyacrylamide gel electrophoresis on 3.3% gels; have identical migration in the native state on 2.7 to 27% gradient polyacrylamide gels; and have a similar amino acid composition within the accuracy of analysis. Human serum demonstrates antigenic identity when diffused against monospecific antisera to both proteins confirming the presence of common antigenic sites on both molecules. Purified human serum opsonic alpha2SB glycoprotein and purified CIg also demonstrate antigenic identity when diffused against monospecific antiserum to either of the isolated proteins. Antiserum to both proteins also inhibits in vitro hepatic Kupffer cell phagocytic uptake of test particles. These results suggest the idenity of these two proteins and reveal a major physiological function for human plasma CIg. Thus, CIg may be important in the regulation of hepatic reticuloendothelial phagocytic activity and nonspecific systemic host defense. This process of systemic host defense has been shown to be depressed in patients following trauma, major surgery, burn injury, and during neoplastic disease, and, in part, mediated by a deficiency or depletion of the alpha2SB glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96117

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Plasma fibronectin concentrations in blood products.

Authors:  J Perttilä; M Salo; O Peltola
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  A study on content and distribution of plasma and tissue fibronectin in rats using ELISA and immunofluorescence.

Authors:  H M Jin
Journal:  J Tongji Med Univ       Date:  1990

3.  Use of biocarrier beads and flow cytometry for single-cell studies of fibronectin gene regulation in dibutyryl cyclic AMP reverse transformed CHO-K1 cells.

Authors:  J M Sterner; J F Leary
Journal:  Cell Biophys       Date:  1989-12

4.  Phagocytosis-promoting activity of avian plasma and fibroblastic cell surface fibronectins.

Authors:  D Marquette; J Molnar; K Yamada; D Schlesinger; S Darby; P Van Alten
Journal:  Mol Cell Biochem       Date:  1981-05-26       Impact factor: 3.396

5.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

6.  Implications for collagen binding from the crystallographic structure of fibronectin 6FnI1-2FnII7FnI.

Authors:  Michèle C Erat; Ulrich Schwarz-Linek; Andrew R Pickford; Richard W Farndale; Iain D Campbell; Ioannis Vakonakis
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

7.  Fibronectin--mediator between cells and connective tissue.

Authors:  H Hörmann
Journal:  Klin Wochenschr       Date:  1982-10-15

8.  Stimulation of human monocyte/macrophage-derived growth factor (MDGF) production by plasma fibronectin.

Authors:  B M Martin; M A Gimbrone; G R Majeau; E R Unanue; R S Cotran
Journal:  Am J Pathol       Date:  1983-06       Impact factor: 4.307

9.  Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

Authors:  W A Scovill; T M Saba; F A Blumenstock; H Bernard; S R Powers
Journal:  Ann Surg       Date:  1978-10       Impact factor: 12.969

10.  Fibronectin in exudative pleural effusions.

Authors:  M Klockars; T Pettersson; T Vartio; H Riska; A Vaheri
Journal:  J Clin Pathol       Date:  1982-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.